CERUS CORP
CERS · NASDAQ
更新於 2026-10-15 06:44:56
- 今日最高
- $2.25
- 今日最低
- $2.21
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $2.23
- 昨天收盤價
- $2.24
- 成交量
- 2.89M
- 市值
- $451.41M
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-0.03
昨天價格區間
52週價格區間
公司概況
- 板塊
- HEALTHCARE
- 行業
- Health Care
- 子行業
- MEDICAL DEVICES
- 總部
- 1220 CONCORD AVENUE, CONCORD, CA, UNITED STATES, 94520
- 國家
- US
- 上市日期
- 1997-01-31
- 財年截止
- December
- 流通股數
- 200.37M
- CIK
- 0001020214
- 官方網址
- www.cerus.com
Cerus Corporation, a biomedical products company, is focused on developing and commercializing the INTERCEPT Blood System to improve blood safety. The company is headquartered in Concord, California.
財務指標
營業收入
2026-06-30
$57.44M
2026-03-31
$53.66M
2025-12-31
$57.75M
2025-09-30
$52.69M
營業支出
2026-06-30
$31.39M
2026-03-31
$28.24M
2025-12-31
$30.39M
2025-09-30
$26.9M
淨利潤
2026-06-30
-$2.94M
2026-03-31
-$1.64M
2025-12-31
-$2.18M
2025-09-30
-$19K
淨利潤率
2026-06-30
-5.11%
2026-03-31
-3.05%
2025-12-31
-3.78%
2025-09-30
-0.03%
每股收益
2026-06-30
$-0.01
2026-03-31
$-0.01
2025-12-31
$-0.01
2025-09-30
$0.00
息稅折舊攤銷前利潤
2026-06-30
-$712K
2026-03-31
$762K
2025-12-31
$292K
2025-09-30
$2.56M
有效稅率
2026-06-30
-3.29%
2026-03-31
-5.84%
2025-12-31
-5.76%
2025-09-30
130.76%
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $57.44M | $53.66M | $57.75M | $52.69M |
| 營業支出 | $31.39M | $28.24M | $30.39M | $26.9M |
| 淨利潤 | -$2.94M | -$1.64M | -$2.18M | -$19K |
| 淨利潤率 | -5.11% | -3.05% | -3.78% | -0.03% |
| 每股收益 | $-0.01 | $-0.01 | $-0.01 | $0.00 |
| 息稅折舊攤銷前利潤 | -$712K | $762K | $292K | $2.56M |
| 有效稅率 | -3.29% | -5.84% | -5.76% | 130.76% |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。